Intermountain Risk Score and Trauma
Verified February 2015 by Intermountain Health Care, Inc.
Information provided by (Responsible Party):
Sarah Majercik, Intermountain Health Care, Inc.
First received: November 6, 2013
Last updated: February 24, 2015
Last verified: February 2015
The investigators hypothesize that a risk score composed of age, sex, and the components of commonly ordered laboratory panels will be predictive of mortality in trauma patients, and will help improve clinicians' ability to make more accurate mortality predictions at the time of admission.
||Observational Model: Case Control
Time Perspective: Prospective
||The Intermountain Risk Score's Association With Mortality Prediction in Trauma Patients
Primary Outcome Measures:
- all cause mortality [ Time Frame: 30 days ] [ Designated as safety issue: No ]
To determine whether the Intermountain Risk Score accurately predicts 30 day mortality and one year mortality in trauma patients.
- all cause mortality [ Time Frame: 1 year ] [ Designated as safety issue: No ]
measure the ability of the Intermountain Risk Score to predict all cause mortality at one year after the traumatic event
Secondary Outcome Measures:
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||December 2016 (Final data collection date for primary outcome measure)
Intermountain Risk Score known
Intermountain Risk Score Unknown
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Individuals who suffer from a traumatic injury and present to the Emergency Department as a Trauma Activation
- Patient presents to Intermountain Medical Center as a Level I or Level II trauma activation.
- Age ≥18
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT02011412
|Intermountain Medical Center
|Murray, Utah, United States, 84107 |
|Contact: Sarah Majercik, MD, MBA firstname.lastname@example.org |
|Principal Investigator: Sarah Majercik, MD, MBA |
|Sub-Investigator: Benjamin D Horne, PhD |
Intermountain Health Care, Inc.
No publications provided
||Sarah Majercik, Sarah Majercik MD, MBA, FACS, Division of Trauma and Surgical Critical Care, Intermountain Health Care, Inc.
History of Changes
|Other Study ID Numbers:
|Study First Received:
||November 6, 2013
||February 24, 2015
||United States: Institutional Review Board
Keywords provided by Intermountain Health Care, Inc.:
Intermountain Risk Score
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on April 30, 2015